Dragoneer Investment Group LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 77 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.2%.

Dragoneer Investment Group ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2021$14,800
-8.9%
1,000,0000.0%0.20%
-6.7%
Q2 2021$16,2401,000,0000.21%